2Decisions
2Patient groups

Added benefit by patient group

  • Non-quantifiable2

Decisions, newest first

Each decision lists only the patient groups coded with this disease.

Akantior

Decision dated 2025-03-20
Non-quantifiableHint
Patientinnen und Patienten ab 12 Jahren mit Akanthamöben-Keratitis

Active substance

Polihexanid

Appropriate comparator therapy

N/A

ICD codes

  • H16.2
Diagnoses
  • Keratitis neuroparalytica

Oxervate

Decision dated 2018-05-03
Non-quantifiable
Erwachsene Patienten mit mittelschwerer (persistierende epitheliale Defekte) oder schwerer (Hornhautgeschwüre) neurotropher Keratitis.

Active substance

Cenegermin

Appropriate comparator therapy

N/A

ICD codes

  • H16.2
Diagnoses
  • Keratitis neuroparalytica

Disease names are the official German titles of ICD-10-GM, version 2026.

Die Erstellung erfolgt unter Verwendung der maschinenlesbaren Fassung des Bundesinstituts für Arzneimittel und Medizinprodukte (BfArM).

In English: created using the machine-readable version of the Federal Institute for Drugs and Medical Devices (BfArM).

Data status: 2026-10-29